50+
Companies
$4B+
Total Funding
6
Key Countries
Strong
EU Regulation

UK Innovation Hub

Oxford, Cambridge, and London's Golden Triangle driving life sciences innovation

Multi-Organ

CN Bio Innovations

PhysioMimix multi-organ MPS. Liver, gut, and connected organ systems. Oxford University spinout.

Cambridge, UK $50M+ Raised
NASDAQ: EXAI

Exscientia

AI-driven drug design. First AI-designed drugs in clinical trials. Oxford spinout. Multiple Big Pharma partnerships.

Oxford Public
DeepMind

Isomorphic Labs

Alphabet/DeepMind spinout. AlphaFold technology. $3B+ Eli Lilly and Novartis deals.

London Alphabet Backed
AMS: BAI

BenevolentAI

Benevolent Platform for target identification. AstraZeneca partnership. SPAC merged.

London Public

Kirkstall

Quasi Vivo perfusion systems. Long-term tissue culture for ADME studies.

York, UK Private

Bit Bio

Precision cellular reprogramming. opti-ox technology. Cambridge spinout. $200M+ raised.

Cambridge Series C

German Engineering Excellence

Berlin, Munich, and the BioRegions driving precision biotech innovation

HUMIMIC

TissUse

HUMIMIC multi-organ chips with integrated circulation. Acquired by ROSEN Group 2023.

Berlin Acquired
Henkel

Phenion

Full-thickness skin models. Henkel subsidiary. FT Skin Model for consumer product testing.

Düsseldorf Henkel

Fraunhofer IGB

Multi-organ-chip research. Government research institute. Stuttgart-based tissue engineering.

Stuttgart Research

Dutch Innovation

Utrecht, Leiden, and Amsterdam life sciences ecosystem

Swiss Precision

Basel, Zurich, and EPFL driving pharmaceutical innovation

3D InSight

InSphero

Scaffold-free 3D microtissues. Akura technology. Liver and pancreatic islet models. 200+ pharma customers.

Zurich Series B
Lung-on-Chip

AlveoliX

Lung-on-chip with breathing mechanics. KYAN platform. University of Bern spinout.

Bern Series A

Readily3D

Tomographic volumetric bioprinting. EPFL spinout. Sub-second printing of complex structures.

Lausanne Seed

French Innovation

Paris, Lyon, and Grenoble biotech clusters

L'Oréal

EpiSkin

Reconstructed skin models. L'Oréal subsidiary. Regulatory-accepted alternatives to animal testing.

Lyon L'Oréal

Poietis

Laser-assisted bioprinting. Skin bioprinting for L'Oréal and BASF partnerships.

Bordeaux Series B

Cherry Biotech

CUBO temperature control for organ-chips. Platform-agnostic technology enabler.

Rennes Series A

Explore Other Regions

Discover human simulation companies across global biotech hubs

North America Asia-Pacific All Companies